Treatment OutcomeFatal OutcomeFournier GangreneRetrospective StudiesPrognosisDebridementCombined Modality TherapyMediastinitisAntirheumatic AgentsFollow-Up StudiesDisease ProgressionArthritis, RheumatoidSurvival RateDrug Therapy, CombinationSurvival AnalysisRisk FactorsTime FactorsBrain NeoplasmsNeoplasm Recurrence, LocalNeoplasm StagingProspective StudiesSeverity of Illness IndexMethotrexateAge FactorsAntineoplastic Combined Chemotherapy ProtocolsUnited StatesTomography, X-Ray ComputedVincristineDisease-Free SurvivalRecurrenceHodgkin DiseaseProstatic NeoplasmsLymphatic MetastasisRisk AssessmentCohort StudiesDoxorubicinKaplan-Meier EstimateSkin NeoplasmsImmunosuppressive AgentsPredictive Value of TestsPostoperative ComplicationsAcute DiseaseCyclophosphamideMagnetic Resonance ImagingCarcinoma, Squamous CellPractice Guidelines as TopicComorbidityAntineoplastic AgentsIncidenceLiver NeoplasmsTumor Markers, BiologicalProportional Hazards ModelsAnti-Bacterial AgentsHypertensionQuality of LifeInfant, NewbornDiabetes Mellitus, Type 2ImmunohistochemistryMultivariate AnalysisBreast Neoplasms